Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
11%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
BBH
26
HOLDINGS
25%
ALSO IN CANC
CANC
48
HOLDINGS
13%
ALSO IN BBH
SECTOR DRIFT (BBH minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 16.2% | 3.3% | 3.3% |
|
BEIGENE LTD. SPONSORED ADR | 2.8% | 2.6% | 2.6% |
|
REGENERON PHARMACEUTICALS | 5.4% | 1.4% | 1.4% |
 |
ARGENX SE ADR | 4.8% | 1.4% | 1.4% |
|
GILEAD SCIENCES INC | 12.8% | 1.3% | 1.3% |
BBH Overweight Relative to CANC
|
AMGEN INC | 12.9% |
|
GILEAD SCIENCES INC | 11.5% |
|
VERTEX PHARMACEUTICALS INC | 10.8% |
|
ALNYLAM PHARMACEUTICALS INC | 4.6% |
|
IQVIA HOLDINGS INC | 4.5% |
|
NATERA INC | 4.2% |
|
REGENERON PHARMACEUTICALS | 3.9% |
|
BIOGEN IDEC INC | 3.6% |
|
INSMED INC | 3.4% |
|
ARGENX SE ADR | 3.4% |
BBH Underweight Relative to CANC
 |
ROCHE HOLDINGS LTD-SPONS ADR | -5.1% |
|
ELI LILLY & CO | -5.0% |
|
BRIDGEBIO PHARMA, INC. | -4.8% |
|
REVOLUTION MEDICINES, INC. | -4.7% |
|
NOVARTIS AG | -4.2% |
|
EXELIXIS INC | -4.0% |
 |
ASTRAZENECA PLC | -3.9% |
 |
MERUS N.V. | -3.7% |
 |
GENMAB A/S SPONSORED ADR | -3.7% |
|
SUMMIT THERAPEUTICS INC | -3.5% |